Hyperlipidemia as a Risk Factor for Cardiovascular Disease

Robert H. Nelson

Research output: Contribution to journalReview articlepeer-review

373 Scopus citations


Elevated levels of blood lipids are well-documented risk factors for cardiovascular disease. Current classification schemes and treatment levels for hyperlipidemia are based on the National Cholesterol Education Panel's Adult Treatment Program-3 (ATP-III) guidelines. Extensive research over the past decade has raised the question whether or not ATP-III guidelines are sufficiently aggressive. New guidelines from ATP-IV are expected to be released in the near future, but in the meantime physicians are faced with uncertainty about how low to target low-density lipoprotein cholesterol, whether to pharmacologically treat high-density lipoprotein cholesterol and triglyceride levels, and how best to achieve target goals.

Original languageEnglish (US)
Pages (from-to)195-211
Number of pages17
JournalPrimary Care - Clinics in Office Practice
Issue number1
StatePublished - Mar 2013


  • CVD risk factors
  • Cardiometabolic risk
  • Dyslipidemia
  • Hypercholesterolemia
  • Hypertriglyceridemia

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'Hyperlipidemia as a Risk Factor for Cardiovascular Disease'. Together they form a unique fingerprint.

Cite this